 |
|
Valve Replacement Using HeterograftsClinical Experience
Katsuji Kubo, MD;
Eugene Mazzei, MD;
Donald G. Mulder, MD
AMA Arch Surg. 1971;102(6):562-565.
Abstract
This report concerns our clinical experience with mounted aortic heterograft valves. There were nine patients, four males and five females, ranging in age from 5 to 65 years. The mitral valve was replaced in eight patients (concomitant tricuspid replacement in one), and the aortic valve in one instance. There was one operative death in a child with complete atrioventricularis communis (AV canal). One patient died after Starr valve replacement of a heterograft which had become infected and obstructed four months after implantation. Another patient developed late valve incompetence due to disruption of a cusp, and the heterograft was successfully replaced with a Starr valve. The seven current survivors, six with heterografts, have good valve function. The follow-up period extends from 3 to 13 months.
Author Affiliations
Los Angeles
From the Department of Surgery (Thoracic), UCLA Medical Center, Los Angeles.
Footnotes
Accepted for publication Feb 12, 1971.
Read before the annual meeting of the Southern California Chapter of the American College of Surgeons, Palm Springs, Calif, Jan 16, 1971.
Reprint requests to Department of Surgery (Thoracic), UCLA Medical Center, Los Angeles 90024 (Dr. Mulder).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
